title: Decreasing the probability of creatine phosphokinase elevations: clinical considerations for daptomycin dosing in obese patients.
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Donovan
authors.forename: John F
authors.initials: JF
authors.lastname: Mohr
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Knapp
authors.forename: Barry I
authors.initials: BI
authors.lastname: Eisenstein
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D016470:Bacteremia / Q000188:drug therapy*; D003402:Creatine Kinase / Q000097:blood*; D017576:Daptomycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D009765:Obesity / Q000150:complications*; D013203:Staphylococcal Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D003402:Creatine Kinase; D017576:Daptomycin